MoonLake Immunotherapeutics (MLTX)
39.74
-1.12
(-2.74%)
USD |
NASDAQ |
May 17, 16:00
39.74
0.00 (0.00%)
After-Hours: 20:00
MoonLake Immunotherapeutics Free Cash Flow: -48.91M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -48.91M |
| December 31, 2023 | -42.78M |
| September 30, 2023 | -42.03M |
| Date | Value |
|---|---|
| June 30, 2023 | -42.13M |
| March 31, 2023 | -50.73M |
| December 31, 2022 | -55.91M |
Free Cash Flow Range, Past 5 Years
-55.91M
Minimum
Dec 2022
-42.03M
Maximum
Sep 2023
-47.08M
Average
-45.85M
Median
Free Cash Flow Benchmarks
| Qiagen NV | 357.85M |
| LENZ Therapeutics Inc | -72.77M |
| AC Immune SA | -48.92M |
| CRISPR Therapeutics AG | -169.05M |
| Addex Therapeutics Ltd | -8.908M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.95M |
| Cash from Investing (Quarterly) | -28.80M |
| Cash from Financing (Quarterly) | 50.98M |
| Free Cash Flow Per Share (Quarterly) | -0.242 |
| Free Cash Flow Yield | -2.24% |